Suppr超能文献

持续非卧床腹膜透析患儿的血清补体系统

The serum complement system in children on continuous ambulatory peritoneal dialysis.

作者信息

Reddingius R E, Schröder C H, Daha M R, Monnens L A

机构信息

Department of Paediatrics, Sint Radboud University Hospital, Nijmegen, The Netherlands.

出版信息

Perit Dial Int. 1993;13(3):214-8.

PMID:8369352
Abstract

OBJECTIVE

During continuous ambulatory peritoneal dialysis (CAPD), the loss of complement factors via the dialysate may cause complement deficiencies. This hypothesis was tested in a group of children treated with CAPD.

DESIGN

Classical (CH50) and alternative (AP50) complement activity and serum levels of factors C1q, C3, C4, C3d, B, D, and P in CAPD patients were compared to normal controls and to children with preterminal renal failure.

SETTING

Patients were seen in a university hospital; normal controls were seen in an outpatient clinic of a general hospital.

PATIENTS

A group of 22 children on CAPD was compared to a normal control group of 44 children and to a group of 12 children with preterminal renal failure with a creatinine clearance below 25 mL/min/1.73 m2.

RESULTS

CH50, AP50, C3, and B were not significantly different from the control group in both the CAPD and preterminal groups. Factors C1q (p = 0.01) and C4, C3d, D, and P (p < 0.001) were higher in the CAPD group in comparison to the normal control group. The factors D (p < 0.001) and P (p = 0.02) were also elevated in the preterminal group. For the measured factors there was no significant difference between the CAPD group and the preterminal group.

CONCLUSIONS

There is no deficiency of complement in children treated with CAPD. High levels of C3d and D can be explained by the reduction of their elimination by the kidney. The increased levels of the other factors are presumably due to increased synthesis in renal failure. This does not seem to be caused by CAPD.

摘要

目的

在持续性非卧床腹膜透析(CAPD)期间,补体因子通过透析液丢失可能导致补体缺乏。该假设在一组接受CAPD治疗的儿童中进行了检验。

设计

将CAPD患者的经典(CH50)和替代(AP50)补体活性以及C1q、C3、C4、C3d、B、D和P因子的血清水平与正常对照组以及终末期前肾衰竭患儿进行比较。

背景

患者在大学医院就诊;正常对照组在综合医院门诊就诊。

患者

将一组22名接受CAPD治疗的儿童与一组44名正常对照儿童以及一组12名肌酐清除率低于25 mL/min/1.73 m²的终末期前肾衰竭儿童进行比较。

结果

CAPD组和终末期前组的CH50、AP50、C3和B与对照组相比无显著差异。与正常对照组相比,CAPD组的C1q(p = 0.01)、C4、C3d、D和P因子(p < 0.001)更高。终末期前组的D(p < 0.001)和P(p = 0.02)因子也升高。对于所测因子,CAPD组和终末期前组之间无显著差异。

结论

接受CAPD治疗的儿童不存在补体缺乏。C3d和D水平升高可通过肾脏对其清除减少来解释。其他因子水平升高可能是由于肾衰竭时合成增加。这似乎不是由CAPD引起的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验